Qual é o preço para DICE Therapeutics, Inc. (DICE)

O preço para DICE Therapeutics, Inc. (DICE) é $47.55

Qual é a capitalização de mercado para DICE Therapeutics, Inc. (DICE)

A capitalização de mercado para DICE Therapeutics, Inc. (DICE) é $1.10B

Histórico de Preços de DICE Therapeutics, Inc. (DICE)

DICE Therapeutics, Inc. is a biopharmaceutical firm focused on creating innovative oral drug candidates to address chronic immunological disorders and other medical conditions. The company leverages its proprietary DELSCAPE platform, engineered to identify highly selective oral small molecules that can modulate protein-protein interactions (PPIs) with efficacy comparable to conventional systemic biologics. Their flagship therapeutic asset is DC-806, an orally administered antagonist designed to inhibit interleukin-17, a pivotal pro-inflammatory signaling molecule widely recognized as a validated target across numerous immunology indications. Furthermore, DICE is advancing other oral treatment options, including therapies aimed at the α4β7 integrin for the management of inflammatory bowel diseases, and compounds targeting the αVβ1/αVβ6 integrin to treat idiopathic pulmonary fibrosis. Beyond these areas, the company also dedicates efforts to immuno-oncology, specifically developing antibody-based therapeutics. Established in 2013, DICE Therapeutics is headquartered in South San Francisco, California.

Ano	Desempenho
2023	45.03%
2022	26.23%
2021	0.00%

Ano

Desempenho

2023

45.03%

2022

26.23%

2021

0.00%

Empresa	Preço da ação	Variação 1a%	País
Vertex Pharmaceuticals Incorporated VRTX.US	$542.09	38.63%	US
Argenx SE ARGX.US	$1.03K	44.13%	NL
CSL Limited CSL.AX	$121.53	-12.70%	AU
Moderna, Inc. MRNA.US	$138.18	473.58%	US
Lonza Group AG LONN.SW	$759.27	7.20%	CH

Empresa

Preço da ação

Variação 1a%

País